P

Inventor

DROHAN WILLIAM N

US43 patents
⚠️ This page may combine multiple inventors who share the name “DROHAN WILLIAM N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMERICAN NAT RED CROSS

22 patents
US7196054B1Mar 27, 2007

Methods for treating wound tissue and forming a supplemented fibrin matrix

AMERICAN NAT RED CROSS94 citations98
US7189410B1Mar 13, 2007

Supplemented and unsupplemented tissue sealants, methods of their production and use

AMERICAN NAT RED CROSS97 citations98
US5880327AMar 9, 1999

Transgenic mammals expressing human coagulation factor VIII

AMERICAN NAT RED CROSS128 citations98
USRE39321EOct 3, 2006

Supplemented and unsupplemented tissue sealants, methods of their production and use

AMERICAN NAT RED CROSS99 citations97
US6193891B1Feb 27, 2001

Methods for the selective separation of organic components from biological fluids

AMERICAN NAT RED CROSS100 citations97
US7229959B1Jun 12, 2007

Supplemented fibrin matrix delivery systems

AMERICAN NAT RED CROSS49 citations96
US5589604ADec 31, 1996

Expression of human protein C in mammary tissue of transgenic mammals

AMERICAN NAT RED CROSS59 citations96
US7208179B1Apr 24, 2007

Methods for treating disease and forming a supplemented fibrin matrix

AMERICAN NAT RED CROSS37 citations95
US6320029B1Nov 20, 2001

Methods of production and use of liquid formulations of plasma proteins

AMERICAN NAT RED CROSS88 citations95
US6096216AAug 1, 2000

Iodinated matrices for disinfecting biological fluids

AMERICAN NAT RED CROSS57 citations94
US5925738AJul 20, 1999

Methods of production and use of liquid formulations of plasma proteins

AMERICAN NAT RED CROSS78 citations94
US6762336B1Jul 13, 2004

Hemostatic sandwich bandage

AMERICAN NAT RED CROSS187 citations93
US6106773AAug 22, 2000

Pathogen inactivating compositions for disinfecting biological fluids

AMERICAN NAT RED CROSS63 citations93
USRE39298ESep 19, 2006

Supplemented and unsupplemented tissue sealants, methods of their production and use

AMERICAN NAT RED CROSS24 citations92
US6518482B2Feb 11, 2003

Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor

AMERICAN NAT RED CROSS25 citations92
US6344596B1Feb 5, 2002

Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals

AMERICAN NAT RED CROSS38 citations92
US6255554B1Jul 3, 2001

Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor

AMERICAN NAT RED CROSS40 citations92
USRE38431EFeb 17, 2004

Methods of production and use of liquid formulations of plasma proteins

AMERICAN NAT RED CROSS56 citations90
US5965789AOct 12, 1999

Engineering protein posttranslational modification by PACE/furin in transgenic non-human mammals

AMERICAN NAT RED CROSS31 citations88
US6262336B1Jul 17, 2001

Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter

AMERICAN NAT RED CROSS9 citations73
US6245548B1Jun 12, 2001

Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate

AMERICAN NAT RED CROSS11 citations71
US7419948B2Sep 2, 2008

Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals

AMERICAN NAT RED CROSS4 citations60

CLEARANT INC

8 patents

SCRIPPS CLINIC RES

2 patents

US HEALTH

2 patents

CHITOGENICS INC

1 patent

UNIV LOYOLA CHICAGO

1 patent

REPAIR INC

1 patent

UNIV NORTH CAROLINA

1 patent

MELOY LAB

1 patent

AVENTIS PHARMA INC

1 patent

AVENTIS PHARM PROD INC

1 patent

VIRGINA TECH INTELLECTUAL PROP

1 patent

APTEVO BIOTHERAPEUTICS LLC

1 patent